FDA clears maggot wound treatment from Singapore startup

The FDA cleared Medifly Maggots, a prescription wound-care product from Singapore-based Cuprina, for maggot debridement therapy. The treatment uses sterile fly larvae to clean non-healing wounds by removing dead tissue. This clearance opens the US market for the Singapore startup's biological wound care approach.